These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1070 related articles for article (PubMed ID: 18927231)

  • 1. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single chain Fv antibodies against the 25-35 Abeta fragment inhibit aggregation and toxicity of Abeta42.
    Zameer A; Schulz P; Wang MS; Sierks MR
    Biochemistry; 2006 Sep; 45(38):11532-9. PubMed ID: 16981713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity.
    Liu R; Yuan B; Emadi S; Zameer A; Schulz P; McAllister C; Lyubchenko Y; Goud G; Sierks MR
    Biochemistry; 2004 Jun; 43(22):6959-67. PubMed ID: 15170333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease.
    Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN
    Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
    Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
    Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intersheet packing interaction in A beta fibrils mapped by disulfide cross-linking.
    Shivaprasad S; Wetzel R
    Biochemistry; 2004 Dec; 43(49):15310-7. PubMed ID: 15581343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques.
    Poduslo JF; Ramakrishnan M; Holasek SS; Ramirez-Alvarado M; Kandimalla KK; Gilles EJ; Curran GL; Wengenack TM
    J Neurochem; 2007 Jul; 102(2):420-33. PubMed ID: 17596213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
    Sakono M; Zako T; Ueda H; Yohda M; Maeda M
    FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting alpha-secretase cleavage of beta-amyloid with engineered proteolytic antibody fragments.
    Kasturirangan S; Brune D; Sierks M
    Biotechnol Prog; 2009; 25(4):1054-63. PubMed ID: 19572401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cloning and expression of human single-chain Fv antibody against amyloid beta peptide involved in Alzheimer's disease].
    Cai J; Wang SZ; Peng Y; Zhong YW; Ji ZJ; Yuan JG; Qiang BQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):557-62. PubMed ID: 14650158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42.
    Finder VH; Vodopivec I; Nitsch RM; Glockshuber R
    J Mol Biol; 2010 Feb; 396(1):9-18. PubMed ID: 20026079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent Abeta-induced neurotoxicity and inhibit fibril formation.
    Lafaye P; Achour I; England P; Duyckaerts C; Rougeon F
    Mol Immunol; 2009 Feb; 46(4):695-704. PubMed ID: 18930548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid.
    Kanapathipillai M; Lentzen G; Sierks M; Park CB
    FEBS Lett; 2005 Aug; 579(21):4775-80. PubMed ID: 16098972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic antibody light chains alter beta-amyloid aggregation and prevent cytotoxicity.
    Liu R; McAllister C; Lyubchenko Y; Sierks MR
    Biochemistry; 2004 Aug; 43(31):9999-10007. PubMed ID: 15287727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of beta-amyloid by proteolytic antibody light chains.
    Rangan SK; Liu R; Brune D; Planque S; Paul S; Sierks MR
    Biochemistry; 2003 Dec; 42(48):14328-34. PubMed ID: 14640701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and development of non-fibrillar amyloid beta as a potential Alzheimer vaccine.
    Subramanian S; Bandopadhyay D; Mishra PK; Mathew M; John M
    Biochem Biophys Res Commun; 2010 Apr; 394(2):393-7. PubMed ID: 20214884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
    Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
    J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.